MedTech Featured Stories
Diabetes: Medtronic launches FDA bid for 1st automated insulin pump
Medtronic filed for FDA pre-market approval for the world's first insulin pump with an automated system to suspend insulin delivery when glucose levels get too low.
Medical device industry titan Medtronic(NYSE:MDT) filed a bid for FDA approval of its MiniMedR 530G system, which the company bills as the world's first insulin pump that delivers and halts insulin automatically, based on sensor readings of a patient's glucose levels.
Regulatory approval for the MiniMedR 530G would bring the market one step closer to an "artificial pancreas," a system that would require minimal patient intervention to monitor and management blood glucose and insulin levels for patients with diabetes.
Return to Previous Page